Clinical Trial: PROGESTERONE-PRIMED OVARIAN STIMULATION VERSUS GONADOTROPHIN-RELEASING HORMONE ANTAGONIST in WOMEN with POLYCYSTIC OVARIAN SYNDROME

U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT06812559) titled 'PROGESTERONE-PRIMED OVARIAN STIMULATION VERSUS GONADOTROPHIN-RELEASING HORMONE ANTAGONIST in WOMEN with POLYCYSTIC OVARIAN SYNDROME' on Feb. 02.

Brief Summary: The purpose of this study is to compare the use of the progesterone-primed ovarian stimulation protocol versus GnRH antagonist protocol in women with polycystic ovarian syndrome (PCOS) regarding the number of oocytes retrieved, percentage of MII oocytes, and the rate of good quality blastocysts available for cryopreservation.

Study Start Date: Dec. 01, 2023

Study Type: OBSERVATIONAL

Condition: Polycystic Ovarian Syndrome (PCOS) Controlled Ovarian Hyperstimulation

Interven...